MODULAR MEDICAL, INC.: 10-K filed 2021-06-29
What MODULAR MEDICAL, INC. reported in its annual report filed 2021-06-29 (fiscal FY 2021): 30 published measures, 61 facts as tagged in accession 0001019056-21-000387.
This filing
- Form
- 10-K (annual report)
- Filed
- 2021-06-29
- Fiscal period
- fiscal FY 2021
- Accession
- 0001019056-21-000387 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MODULAR MEDICAL, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 2,248,171 | USD | |
| At 2020-03-31 | 3,858,551 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 3,523,320 | USD | |
| At 2020-03-31 | 980,129 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | -1,275,149 | USD | |
| At 2020-03-31 | 2,878,422 | USD | |
| At 2019-03-31 | 6,474,057 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 1,468,465 | USD | |
| At 2020-03-31 | 3,122,134 | USD | |
| At 2019-03-31 | 6,553,768 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | -7,377,976 | USD | 365 |
| 2019-04-01 to 2020-03-31 | -5,320,873 | USD | 366 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | -5,908,662 | USD | 365 |
| 2019-04-01 to 2020-03-31 | -4,094,839 | USD | 366 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 109,669 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 260,789 | USD | 366 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 4,364,662 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 923,994 | USD | 366 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | -109,669 | USD | 365 |
| 2019-04-01 to 2020-03-31 | -260,789 | USD | 366 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | -15,947,010 | USD | |
| At 2020-03-31 | -8,569,034 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 1,600 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 1,600 | USD | 366 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 298,958 | USD | |
| At 2020-03-31 | 301,308 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 1,227,578 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 801,244 | USD | 366 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | -7,336,715 | USD | 365 |
| 2019-04-01 to 2020-03-31 | -5,348,022 | USD | 366 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 1,649,089 | USD | |
| At 2020-03-31 | 3,186,293 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | -39,791 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 0 | USD | 366 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 3,296,965 | USD | |
| At 2020-03-31 | 661,393 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 7,336,715 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 5,348,022 | USD | 366 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 4,083,303 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 3,034,152 | USD | 366 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 18,906,148 | shares | |
| At 2020-03-31 | 17,870,261 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 14,652,955 | USD | |
| At 2020-03-31 | 10,505,592 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 200,124 | USD | |
| At 2020-03-31 | 270,950 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 309,855 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 451,049 | USD | |
| At 2020-03-31 | 353,001 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 152,091 | USD | |
| At 2020-03-31 | 51,692 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 42,000 | USD | |
| At 2020-03-31 | 140,000 | USD |
Net deferred tax assets
Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-03-31 | 0 | USD | |
| At 2020-03-31 | 0 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | -7,376,376 | USD | 365 |
| 2019-04-01 to 2020-03-31 | -5,319,273 | USD | 366 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 3,253,412 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 2,313,870 | USD | 366 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2021-03-31 | 1,600 | USD | 365 |
| 2019-04-01 to 2020-03-31 | 1,600 | USD | 366 |
Inspect the source
- Entity
- MODULAR MEDICAL, INC. / CIK 0001074871
- Captured
- 2026-09-20T05:20:05.018Z
- SEC response SHA-256
35d9c7a349fec6383baca56e8aa4820d6d19d2f4955371898b75285f3bf308e4
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001074871.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))